These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20825621)

  • 21. Sensitivity of Preference-Based Quality-of-Life Measures for Economic Evaluations in Early-Stage Melanoma.
    Dieng M; Kasparian NA; Cust AE; Costa DSJ; Tran A; Butow PN; Menzies SW; Mann GJ; Morton RL
    JAMA Dermatol; 2018 Jan; 154(1):52-59. PubMed ID: 29188268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experiences and challenges in implementing complex community-based research project: the Pacific Obesity Prevention in Communities project.
    Schultz JT; Moodie M; Mavoa H; Utter J; Snowdon W; McCabe MP; Millar L; Kremer P; Swinburn BA
    Obes Rev; 2011 Nov; 12 Suppl 2():12-9. PubMed ID: 22008555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construct validity of the Assessment of Quality of Life - 6D (AQoL-6D) in community samples.
    Allen J; Inder KJ; Lewin TJ; Attia JR; Kelly BJ
    Health Qual Life Outcomes; 2013 Apr; 11():61. PubMed ID: 23590808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing Outcomes for Cost-Utility Analysis in Children and Adolescents With Mental Health Problems: Are Multiattribute Utility Instruments Fit for Purpose?
    Mihalopoulos C; Chen G; Scott JG; Bucholc J; Allen C; Coghill D; Jenkins P; Norman R; Ratcliffe J; Richardson J; Stathis S; Viney R
    Value Health; 2023 May; 26(5):733-741. PubMed ID: 36535579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of living with a functional and aesthetic nasal deformity after primary rhinoplasty: a utility outcomes score assessment.
    Sinno H; Izadpanah A; Thibaudeau S; Christodoulou G; Tahiri Y; Slavin SA; Lin SJ
    Ann Plast Surg; 2012 Oct; 69(4):431-4. PubMed ID: 22964667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deriving health utility indices from a food allergy quality-of-life questionnaire.
    Chen G; DunnGalvin A; Greenhawt M; Shaker M; Campbell DE
    Pediatr Allergy Immunol; 2021 Nov; 32(8):1773-1780. PubMed ID: 34311507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population norms and meaningful differences for the Assessment of Quality of Life (AQoL) measure.
    Hawthorne G; Osborne R
    Aust N Z J Public Health; 2005 Apr; 29(2):136-42. PubMed ID: 15915617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Pacific OPIC Project (Obesity Prevention in Communities): action plans and interventions.
    Schultz J; Utter J; Mathews L; Cama T; Mavoa H; Swinburn B
    Pac Health Dialog; 2007 Sep; 14(2):147-53. PubMed ID: 19588622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A view from the bridge: agreement between the SF-6D utility algorithm and the Health Utilities Index.
    O'Brien BJ; Spath M; Blackhouse G; Severens JL; Dorian P; Brazier J
    Health Econ; 2003 Nov; 12(11):975-81. PubMed ID: 14601159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Pacific Obesity Prevention in Communities (OPIC) project.
    Uauy R; Corvalan C; Kain J
    Obes Rev; 2011 Nov; 12 Suppl 2():1-2. PubMed ID: 22008553
    [No Abstract]   [Full Text] [Related]  

  • 31. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The utility score of epilepsy with partial seizure measured by TTO, VAS, and EQ-5D in the general Korean population.
    Kang HJ; Kang E; Jo MW; Park EJ; Yoon S; Lee EK
    Epilepsy Res; 2014 Jul; 108(5):963-71. PubMed ID: 24679945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A note on the nature of utility in time and health and implications for cost utility analysis.
    Buckingham KJ; Devlin NJ
    Soc Sci Med; 2009 Jan; 68(2):362-7. PubMed ID: 19019518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Valuing SF-6D Health States Using a Discrete Choice Experiment.
    Norman R; Viney R; Brazier J; Burgess L; Cronin P; King M; Ratcliffe J; Street D
    Med Decis Making; 2014 Aug; 34(6):773-86. PubMed ID: 24025661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Valuations of epilepsy-specific health states: a comparison of patients with epilepsy and the general population.
    Mulhern B; Rowen D; Snape D; Jacoby A; Marson T; Hughes D; Baker G; Brazier J
    Epilepsy Behav; 2014 Jul; 36():12-7. PubMed ID: 24836527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. QALY weights for diabetic retinopathy--a comparison of health state valuations with HUI-3, EQ-5D, EQ-VAS, and TTO.
    Heintz E; Wiréhn AB; Peebo BB; Rosenqvist U; Levin LÅ
    Value Health; 2012 May; 15(3):475-84. PubMed ID: 22583458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The development of a model for translation of the Neck Disability Index to utility scores for cost-utility analysis in cervical disorders.
    Richardson SS; Berven S
    Spine J; 2012 Jan; 12(1):55-62. PubMed ID: 22209244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health values of adolescents with cystic fibrosis.
    Yi MS; Britto MT; Wilmott RW; Kotagal UR; Eckman MH; Nielson DW; Kociela VL; Tsevat J
    J Pediatr; 2003 Feb; 142(2):133-40. PubMed ID: 12584533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
    Petrou S; Hockley C
    Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do quality-adjusted life years take account of lost income? Evidence from an Australian survey.
    Richardson J; Peacock SJ; Iezzi A
    Eur J Health Econ; 2009 Feb; 10(1):103-9. PubMed ID: 18458973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.